174 related articles for article (PubMed ID: 17623022)
1. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model.
Butovsky O; Kunis G; Koronyo-Hamaoui M; Schwartz M
Eur J Neurosci; 2007 Jul; 26(2):413-6. PubMed ID: 17623022
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
[TBL] [Abstract][Full Text] [Related]
3. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
Butovsky O; Koronyo-Hamaoui M; Kunis G; Ophir E; Landa G; Cohen H; Schwartz M
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11784-9. PubMed ID: 16864778
[TBL] [Abstract][Full Text] [Related]
4. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
5. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
7. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.
Simard AR; Rivest S
Mol Psychiatry; 2006 Apr; 11(4):327-35. PubMed ID: 16491130
[TBL] [Abstract][Full Text] [Related]
9. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.
Grutzendler J; Helmin K; Tsai J; Gan WB
Ann N Y Acad Sci; 2007 Feb; 1097():30-9. PubMed ID: 17413007
[TBL] [Abstract][Full Text] [Related]
10. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
11. Rat microglia exhibit increased density on Alzheimer's plaques in vitro.
Joshi SN; Crutcher KA
Exp Neurol; 1998 Jan; 149(1):42-50. PubMed ID: 9454613
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic signaling, microglia, and Alzheimer's disease senile plaques: is there a connection?
Luca M; Chavez-Ross A; Edelstein-Keshet L; Mogilner A
Bull Math Biol; 2003 Jul; 65(4):693-730. PubMed ID: 12875339
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
15. Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete.
MacDonald AB
Med Hypotheses; 2006; 67(3):592-600. PubMed ID: 16675154
[TBL] [Abstract][Full Text] [Related]
16. Targeting the hematopoietic system for the treatment of Alzheimer's disease.
Lampron A; Gosselin D; Rivest S
Brain Behav Immun; 2011 Jun; 25 Suppl 1():S71-9. PubMed ID: 21195165
[TBL] [Abstract][Full Text] [Related]
17. Bone-marrow-derived microglia: myth or reality?
Soulet D; Rivest S
Curr Opin Pharmacol; 2008 Aug; 8(4):508-18. PubMed ID: 18487084
[TBL] [Abstract][Full Text] [Related]
18. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model.
Wu QY; Li J; Feng ZT; Wang TH
Neurosci Lett; 2007 May; 417(3):281-5. PubMed ID: 17412501
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
